SCHEMBL280507

SCHEMBL280507

c1ccc2c(c1)c1ccccc1n2-c1ccc2oc3ccc(-n4ccnc4)cc3c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.48
CYP11B2 P19099 4/20 0.48
CYP19A1 P11511 3/20 0.48
CYP3A4 P08684 2/20 0.44
MEN1 O00255 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
IDO1 P14902 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
ENPP2 Q13822 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
NOTUM Q6P988 1/20 0.39
FGFR1 P11362 1/20 0.38
FLT1 P17948 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30843246 0.88 CYP11B1 (0.54) CYP11B1CYP11B2CYP19A1CYP3A4MEN1
SCHEMBL822818 0.88 CYP11B1 (0.54) CYP11B1CYP11B2CYP19A1CYP3A4MEN1
SCHEMBL28518290 0.83 CYP3A4 (0.56) CYP11B1CYP11B2CYP19A1CYP3A4MEN1
SCHEMBL29551183 0.83 KDM4E (0.52) CYP3A4MEN1KMT2AMAOAMAPT
SCHEMBL5028280 0.83 KDM4E (0.52) CYP3A4MEN1KMT2AMAOAMAPT
SCHEMBL15390058 0.82 CYP3A4 (0.56) CYP11B1CYP11B2CYP19A1CYP3A4MEN1
SCHEMBL29647885 0.81 CYP3A4 (0.61) CYP11B1CYP11B2CYP19A1CYP3A4MEN1
SCHEMBL29099377 0.81 CYP3A4 (0.61) CYP11B1CYP11B2CYP19A1CYP3A4MEN1
SCHEMBL18381831 0.81 KDM4E (0.50) CYP3A4MEN1TSHRKMT2AMAOA
SCHEMBL19082983 0.81 CYP3A4 (0.36) CYP11B1CYP11B2CYP19A1CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590967-B1 USE OF DIBENZOFURANS AND DIBENZOTHIOPHENES SUBSTITUTED BY NITROGEN-BONDED FIVE-MEMBERED HETEROCYCLIC RINGS IN ORGANIC ELECTRONICS UDC IRELAND LTD (IE) 2019-05-15 EP disclosed
US-9067919-B2 Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics BASF SE (DE) 2015-06-30 US disclosed
US-9067919-B2 Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics BASF SE (DE) 2015-06-30 US disclosed
WO-2012004765-A2 USE OF DIBENZOFURANS AND DIBENZOTHIOPHENES SUBSTITUTED BY NITROGEN-BONDED FIVE-MEMBERED HETEROCYCLIC RINGS IN ORGANIC ELECTRONICS BASF SE (DE) 2012-01-12 WO disclosed
US-20120007063-A1 USE OF DIBENZOFURANS AND DIBENZOTHIOPHENES SUBSTITUTED BY NITROGEN-BONDED FIVE-MEMBERED HETEROCYCLIC RINGS IN ORGANIC ELECTRONICS BASF SE (DE) 2012-01-12 US disclosed
US-20120007063-A1 USE OF DIBENZOFURANS AND DIBENZOTHIOPHENES SUBSTITUTED BY NITROGEN-BONDED FIVE-MEMBERED HETEROCYCLIC RINGS IN ORGANIC ELECTRONICS BASF SE (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120007063-A1 USE OF DIBENZOFURANS AND DIBENZOTHIOPHENES SUBSTITUTED BY NITROGEN-BONDED FIVE-MEMBERED HETEROCYCLIC RINGS IN ORGANIC ELECTRONICS DDT, DBF4, POU5F1 CYP11B1 652/4885CYP11B2 622/4885CYP19A1 2030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.